United States· US:87036-028_435eca0d-7968-83ba-e063-6294a90aa688
ODLUMIVIE Salmon DNA Repairing Serum
A medicinal product containing rh-oligopeptide-1, registered in United States by OD’LUMIVIE.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- RH-OLIGOPEPTIDE-1
- Manufacturer
- OD’LUMIVIE
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11870360280140 mL in 1 BOTTLE (87036-028-01)
- ndc1187036-028-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ef2367f7-4829-4f5e-8082-e6c5ce4554d2 GET /v1/drugs/ef2367f7-4829-4f5e-8082-e6c5ce4554d2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "CUTANEOUS",
"source": "ndc",
"strength": "1",
"substance": "RH-OLIGOPEPTIDE-1",
"productndc": "87036-028",
"dosage_form": "LIQUID",
"dea_schedule": null,
"strength_unit": "g/100mL",
"application_number": "M016",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about rh-oligopeptide-1.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.